Maybe
not of immediate relevance to me, but
this article from the American Society of Hematology discussed the latest
treatments in C.L.L.
Basically
the treatment involves giving anti-CD20.
CD20 is a B-lymphocyte marker. I can remember this approach being in the realms
of science-fiction when I was at college…
No comments:
Post a Comment